Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first-episode or multi-episode schizophrenia

AIM: The aim of this study was to examine the speed of response, doses, and safety of treatment with second-generation antipsychotics (SGAs) in patients at ultra-high risk (UHR) compared to those with schizophrenia. METHODS: A 12-week open-label, prospective study of SGAs was performed in UHR patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Washida, Kenji, Takeda, Toshihiko, Habara, Toshiaki, Sato, Soichiro, Oka, Takuro, Tanaka, Masuo, Yoshimura, Yusaku, Aoki, Shozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693825/
https://www.ncbi.nlm.nih.gov/pubmed/23818786
http://dx.doi.org/10.2147/NDT.S45697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693825/
https://www.ncbi.nlm.nih.gov/pubmed/23818786
http://dx.doi.org/10.2147/NDT.S45697

Ejemplares similares